Drug
Dsp 1083 Implantation
Dsp 1083 Implantation: highest development phase Phase 1/2, developed by Sumitomo Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Sumitomo Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| DSP-1083 implantation NCT06753331 | Phase 1/2 | Parkinson's Disease |
Latest
No recent events.
Follow Dsp 1083 Implantation on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.